What If Nicotine Were Classified Like Cocaine? Palau’s Bold UN Proposal Could Change Everything

Ngerulmud, Palau, MMN Correspondent: Imagine a world where buying a nicotine pouch is as difficult as obtaining a prescription painkiller. That’s exactly what the tiny Pacific nation of Palau is asking the United Nations to consider. With a population smaller than many small towns, this island country is taking on the global tobacco industry with a proposal that could reshape how we think about addiction.

Palau has officially petitioned the UN to reclassify nicotine as a controlled substance, placing it alongside drugs like amphetamines and cocaine under international law. It’s a move that sounds extreme at first, but when you look at the numbers, the logic starts to click. According to the World Health Organization, over 1.2 billion people worldwide are hooked on nicotine, and roughly 7 million die each year from tobacco related diseases. Yet, while cigarettes have faced decades of regulation, newer products like vapes and nicotine pouches have largely flown under the radar.

Here’s where it gets interesting. Palau isn’t just talking about old school smoking. They’re targeting the entire category of nicotine containing products, including the sleek, flavored vapes and discreet pouches that have become wildly popular among teenagers. In 2021, nearly 30% of adolescents aged 9 to 20 in Palau had used vapes. That statistic alone pushed the government to ban vaping imports and sales in 2023. First Lady Valerie Whipps, who leads the Coalition for Tobacco Free Palau, put it simply: “This is about our children.” She points out that young people across the Pacific are being marketed products that have never undergone proper scientific review under UN frameworks.

The science behind the proposal is straightforward. Nicotine itself isn’t a carcinogen, but it is profoundly addictive. It rewires the developing brain, especially in adolescents, making them more susceptible to long term dependence. And here’s a fact that might surprise you: studies show that teenagers who vape are nine times more likely to start smoking cigarettes later. That means the progress made in reducing smoking rates over the past few decades could be undone by a new generation of nicotine users.

Right now, there’s no global consensus on how to handle these products. Some countries treat vapes like tobacco, others like consumer electronics, and a few like medical devices. This patchwork approach creates loopholes that manufacturers are happy to exploit. Nicotine pouches, for example, are small, discreet, and often sold without age verification or health warnings. They’re marketed with flavors like mango and mint, making them especially appealing to minors.

If Palau’s proposal gains traction, the UN would ask every member nation to assess the risks of all nicotine containing products. The result could be a world where only medically approved forms of nicotine, like patches, gum, or inhalers, are legally available. Everything else, from flavored vapes to nicotine laced snacks, would require strict medical supervision or be banned outright.

Of course, not everyone thinks this is realistic. Renee Bittoun, a nicotine treatment specialist at the Woolcock Institute of Medical Research in Sydney, acknowledges the scientific merit but doubts the proposal will succeed. “Tobacco companies wield enormous influence,” she says. “They will push back hard against any attempt to elevate nicotine to the same legal status as narcotics.” And she’s right. Industry lobbying has historically shaped global health policy, often delaying or weakening regulations.

But here’s the thing: the conversation is already shifting. The WHO Framework Convention on Tobacco Control was designed for combustible cigarettes, not for the rapid evolution of nicotine delivery systems. As new products emerge, some containing synthetic nicotine and others using novel aerosolization methods, the gap between regulation and innovation keeps widening. Palau’s initiative is forcing the world to ask whether our current frameworks are enough.

Support for stricter controls is growing beyond the Pacific. The European Union now includes certain vaping products under stringent rules, including flavor bans and packaging requirements. Canada and Australia have implemented age verification systems and advertising restrictions. But enforcement is uneven, and many low and middle income countries lack the resources to keep up.

Palau’s case highlights a fascinating paradox. While tobacco related deaths remain high, the rise of alternative nicotine products has created new public health challenges. The WHO reports that electronic cigarettes are linked to respiratory issues, including EVALI, which led to thousands of hospitalizations in the U.S. during peak outbreaks. Long term effects on cardiovascular health and mental well being are still being studied, but early findings suggest serious risks.

As Palau pushes forward with its UN petition, the world is watching. The outcome could redefine how nations approach nicotine regulation, not just as a component of tobacco, but as a standalone public health threat. If successful, this move could set a precedent for other nations, especially those with vulnerable youth populations, to adopt more protective measures.

The debate also raises a deeper question: should a substance with proven addictive potential be freely marketed and sold without medical oversight? Can societies afford to treat nicotine as a lifestyle choice when millions are already dependent? With billions at stake and lives hanging in the balance, Palau’s small but determined voice may be the catalyst for a global reckoning with nicotine, one that could reshape public health policy for generations to come.